Pharma Stock Roundup LLYs Zepbound Success, FDA Updates for MRK, JNJ
| TNBCX Fund | USD 19.75 0.00 0.00% |
Slightly above 56% of 1290 Smartbeta's investor base is looking to short. The analysis of overall sentiment of trading 1290 Smartbeta Equity mutual fund suggests that many investors are alarmed at this time. 1290 Smartbeta's investing sentiment can be driven by a variety of factors including economic data, 1290 Smartbeta's earnings reports, geopolitical events, and overall market trends.
1290 |
LLYs Zepbound shows better weight loss than NVOs Wegovy in a study. FDA updates for MRK, RHHBY, JNJ and AZN drugs grab headlines.
Read at zacks.com
 |
1290 Smartbeta Fundamental Analysis
We analyze 1290 Smartbeta's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of 1290 Smartbeta using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of 1290 Smartbeta based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Five Year Return
Five Year Return Comparative Analysis
1290 Smartbeta is currently under evaluation in five year return among similar funds. Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.
1290 Smartbeta Equity Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with 1290 Smartbeta mutual fund to make a market-neutral strategy. Peer analysis of 1290 Smartbeta could also be used in its relative valuation, which is a method of valuing 1290 Smartbeta by comparing valuation metrics with similar companies.
Peers
1290 Smartbeta Related Equities
| TNHIX | 1290 High | 0.23 | ||||
| 70082LAB3 | 70082LAB3 | 0.18 | ||||
| LBHIX | Thrivent High | 0.23 | ||||
| RRTLX | T Rowe | 0.39 | ||||
| VIASP | Via Renewables | 0.40 | ||||
| MSTSX | Morningstar Unconstrained | 0.67 | ||||
| SITKF | Sitka Gold | 3.85 | ||||
| TNVIX | 1290 Gamco | 4.88 |
Other Information on Investing in 1290 Mutual Fund
1290 Smartbeta financial ratios help investors to determine whether 1290 Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 1290 with respect to the benefits of owning 1290 Smartbeta security.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |